191 related articles for article (PubMed ID: 8342505)
1. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
Am J Cardiol; 1993 Aug; 72(3):280-7. PubMed ID: 8342505
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
[TBL] [Abstract][Full Text] [Related]
3. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
[TBL] [Abstract][Full Text] [Related]
4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone: clinical trials.
Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
[TBL] [Abstract][Full Text] [Related]
6. Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.
Wang CH; Chang WT; Huang CH; Tsai MS; Yu PH; Wu YW; Liu YB; Chen WJ
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):327-334. PubMed ID: 31255419
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
Kudenchuk PJ; Cobb LA; Copass MK; Cummins RO; Doherty AM; Fahrenbruch CE; Hallstrom AP; Murray WA; Olsufka M; Walsh T
N Engl J Med; 1999 Sep; 341(12):871-8. PubMed ID: 10486418
[TBL] [Abstract][Full Text] [Related]
8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
Tsai CF; Chen SA; Tai CT; Chiang CE; Ding YA; Chang MS
Int J Cardiol; 1998 Mar; 64(1):47-55. PubMed ID: 9579816
[TBL] [Abstract][Full Text] [Related]
12. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
13. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.
Valdes SO; Donoghue AJ; Hoyme DB; Hammond R; Berg MD; Berg RA; Samson RA;
Resuscitation; 2014 Mar; 85(3):381-6. PubMed ID: 24361455
[TBL] [Abstract][Full Text] [Related]
14. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
Yap YG; Camm AJ
Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).
Kuck KH; Cappato R; Siebels J; Rüppel R
Circulation; 2000 Aug; 102(7):748-54. PubMed ID: 10942742
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Kudenchuk PJ; Brown SP; Daya M; Rea T; Nichol G; Morrison LJ; Leroux B; Vaillancourt C; Wittwer L; Callaway CW; Christenson J; Egan D; Ornato JP; Weisfeldt ML; Stiell IG; Idris AH; Aufderheide TP; Dunford JV; Colella MR; Vilke GM; Brienza AM; Desvigne-Nickens P; Gray PC; Gray R; Seals N; Straight R; Dorian P;
N Engl J Med; 2016 May; 374(18):1711-22. PubMed ID: 27043165
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
Van Herendael H; Dorian P
Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
[TBL] [Abstract][Full Text] [Related]
18. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
Connolly SJ; Gent M; Roberts RS; Dorian P; Roy D; Sheldon RS; Mitchell LB; Green MS; Klein GJ; O'Brien B
Circulation; 2000 Mar; 101(11):1297-302. PubMed ID: 10725290
[TBL] [Abstract][Full Text] [Related]
19. Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Haverkamp W; Eckardt L; Borggrefe M; Breithardt G
Am J Cardiol; 1997 Oct; 80(8A):67G-73G. PubMed ID: 9354413
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
Dorian P; Cass D; Schwartz B; Cooper R; Gelaznikas R; Barr A
N Engl J Med; 2002 Mar; 346(12):884-90. PubMed ID: 11907287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
